Immuneering Corporation (IMRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 289.6M |
| Enterprise Value | 164.78M |
| P/E Ratio | -3.6 |
| PEG Ratio | -0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.27 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -3.31 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -0.28 |
| Return On Equity | -0.27 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -698,887 |
| EBITDA | -55.67M |
| Net Income | -56.02M |
| Diluted EPS | -1.27 |
Balance Sheet
| Total Cash | 149.9M |
| Total Cash/Share | 2.32 |
| Total Debt | 3.63M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 19.47 |
| Book Value Per Share | 2.95 |
Price History
| 52-Week Change | -30.09 |
| 52-Week High | 8.48 |
| 52-Week Low | 3.38 |
| Moving Average 50 Days | 4.47 |
| Moving Average 200 Days | 4.86 |
Statistics
| Average Volume | 681,595 |
| Shares Outstanding | 64.7M |
| % Held by Institutions | 78.66 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
